Hyperion DeFi Inc SEC Filings

Hyperion DeFi, Inc. filed an initial insider ownership report for its General Counsel, Robert Rubenstein, stating that he does not beneficially own any company securities.

The filing identifies Rubenstein as an officer of Hyperion DeFi, serving as General Counsel, and confirms that no non-derivative or derivative securities are beneficially owned as of the reported date. The document also references a power of attorney authorizing the execution of this report.

Hyperion DeFi, Inc. reported insider share purchases by a director. A Form 4 filing shows open-market buys of 18,742 shares of common stock on 12/18/2025 at a volume-weighted average price of $3.1389 per share and an additional 19,702 shares at a volume-weighted average price of $3.1385 per share. These prices reflect multiple trades executed between $3.04 and $3.22 per share. Following these transactions, the reporting person beneficially owns 75,448 shares directly and 95,150 shares indirectly through a spouse.

Hyperion DeFi, Inc. entered into a Sales Agreement allowing an at-the-market offering of up to $500,000,000 of common stock under its Form S-3 shelf registration. The company can instruct Cantor Fitzgerald & Co. and Chardan Capital Markets, LLC to sell shares from time to time through regular market trades, block trades, or other permitted methods on The Nasdaq Capital Market or elsewhere. The Sales Agents will use commercially reasonable efforts to place the stock and will receive a commission equal to 4.0% of the gross sales proceeds for shares sold. Hyperion DeFi is not required to sell any shares, and the program will end when all authorized shares are sold or the agreement is terminated.

Hyperion DeFi, Inc. has filed a Form S-3 shelf registration to offer up to $1,000,000,000 of securities, including common stock, preferred stock, warrants, debt securities, units and rights, in one or more future offerings. Within this, a separate sales agreement prospectus covers up to $500,000,000 of common stock that may be issued from time to time through at-the-market transactions under a Sales Agreement with Cantor Fitzgerald & Co. and Chardan Capital Markets, LLC. The company’s common stock trades on Nasdaq under the symbol HYPD and last closed at $4.97 per share on November 13, 2025. As of September 30, 2025, Hyperion DeFi had 7,162,659 shares of common stock, 5,435,897 shares of Series A Preferred Stock and warrants to purchase 33,820,785 shares outstanding.

Hyperion DeFi, formerly Eyenovia, is building a strategic treasury of HYPE tokens tied to the Hyperliquid blockchain while operating a validator and related DeFi services, and it continues to develop its Optejet ophthalmic liquid delivery device. The company is a smaller reporting company and may use net proceeds from any future sales for general corporate purposes such as working capital, capital expenditures, debt repayment and potential acquisitions, with specific uses to be detailed in later prospectus supplements.

Hyperion DeFi, Inc. reported a sharp turnaround in Q3 2025 as it pivoted to a digital‑asset treasury strategy centered on HYPE tokens. Net income was $6.6 million for the quarter, compared with a loss a year ago, driven by realized and unrealized gains on HYPE and a gain on extinguishment of liabilities. Revenue reached $302,506 from native staking and validator commissions. Cash was $8.2 million, total assets $82.8 million, and stockholders’ equity improved to $70.8 million.

The company raised capital through an ATM and a private placement, including $50.0 million of Series A Preferred Stock with accompanying warrants, and expanded authorized shares. It began acquiring and staking HYPE in July, ending the quarter with HYPE digital assets of $37.95 million and digital intangible assets (primarily HiHYPE) of $35.02 million, offset by a $6.29 million impairment. The Avenue loan was amended to extend maturity to July 1, 2028, reduce the rate to 8% (half cash/half PIK), and add warrants. Common shares outstanding were 7,162,659 as of September 30, 2025; 8,097,659 as of November 10, 2025.

Hyperion DeFi, Inc. announced its financial results for the quarter ended September 30, 2025. The company made a press release available and provided an investor presentation to accompany the disclosure.

Hyperion DeFi is hosting a conference call on November 13, 2025 to discuss its quarterly financial and operating results. The company’s common stock trades on the Nasdaq Capital Market under the symbol HYPD.

Hyperion DeFi (HYPD) filed an 8-K detailing two blockchain operating agreements and a leadership change. The company entered a Joint Validator Operators’ Agreement with Kinetiq Research and Pier Two, effective retroactively to June 25, 2025, to run a co-branded validator on the Hyperliquid Layer-1. Hyperion initiated the validator with 10,000 HYPE and will provide staking capital from its HYPE treasury. Kinetiq supplies operations support and tooling, while Pier Two hosts and manages infrastructure with ISO/IEC 27001 and SOC 2 compliance.

The agreement includes revenue sharing of validator-level rewards, quorum-based key management, service levels, and slashing risk provisions. It runs for an initial one-year term with automatic annual renewals and 90 days’ termination notice, with additional default and force majeure rights. Separately, Hyperion signed a HAUS Agreement with Felix Foundation to allocate 500,000 HYPE to a joint wallet to meet HIP-3 requirements for launching a perpetual futures market, under which Hyperion receives tiered market revenues plus 100% of staking rewards; the term is 52 weeks with 26-week auto-renewals and 30 days’ notice. The previously announced CEO resignation takes effect on November 1, 2025.

Insider reported receipt of restricted stock units totaling 300,000 shares of Hyperion DeFi, Inc. (HYPD). David R. Knox, identified as a director and the company's Chief Financial Officer, reported two grants dated 09/29/2025 that together increase his direct beneficial ownership to 300,000 shares.

The first grant covers 100,000 RSUs vesting in two equal tranches of 50,000 on 03/29/2026 and 09/29/2026, subject to continued employment. The second grant covers 200,000 RSUs that vest upon achieving market-cap milestones: 100,000 RSUs at $150 million and 100,000 RSUs at $500 million, each measured as the threshold met on ten trading days within a rolling 30-day period, subject to continued employment. All reported transactions have a $0 price.